Abiraterone acetate (AA) or docetaxel (D) in metastatic castration-sensitive prostate cancer (mCSPC): A systematic review and network meta-analysis of randomized clinical trials (RCTs).

Authors

Zeeshan Ali MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

2-2018

Volume

36

Issue

6

Published In/Presented At

https://doi.org/10.1200/JCO.2018.36.6_suppl.24

Disciplines

Medicine and Health Sciences

Department(s)

Hematology-Medical Oncology Division, Hematology-Medical Oncology Division Fellows and Residents, Fellows and Residents

Document Type

Article